Auto BMT for Non-M3 AML in 1st Remission in Pts </=60y of Age Using Busulfan/FTBI & VP16 as a Prep R

NCT00534469 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

BIOLOGICAL: aldesleukin
BIOLOGICAL: filgrastim
DRUG: busulfan
DRUG: cytarabine
DRUG: etoposide
DRUG: idarubicin
PROCEDURE: autologous hematopoietic stem cell transplantation
PROCEDURE: bone marrow transplantation
PROCEDURE: peripheral blood stem cell transplantation
RADIATION: total-body irradiation

Sponsor

City of Hope Medical Center

Collaborators

[object Object]